medigraphic.com

2014, Number S1

<< Back Next >>

Rev Mex Anest 2014; 37 (S1)

Intravenous perfusion of anesthetic agents: Of molecular biology to clinical scenarios

González-Oviedo R

Language: Spanish
References: 44
Page: 259-270
PDF size: 224.66 Kb.


Text Extraction

No abstract


REFERENCES

  1. Kaplan JA. Evolution of cardiac anesthesia and surgery. Kaplan’s cardiac anesthesia. 5th. ed. Philadelphia, USA: Saunders Elsevier; 2006.

  2. Karenblosch J, Stienen GJ, et al. The differential effect of propofol on contractility of isolated myocardial trabeculae of rat and guinea-pig. Br J Anesth. 2001;132:742-748.

  3. Gelissen HP, Epema AH, et al. Inotropic effect of propofol, tiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology. 1996;84:397-403.

  4. Ko SH, Yu CW, Lee SK, et al. Propofol attenuates isquemia-reperfusion injury in the isolated rat heart. Anesth Analg. 1997;85:719.

  5. Yang CY, Wu WC, Chai CY, et al. Propofol inhibits neuronal firing activities in the caudal ventrolateral medulla. Chang Gung Med J. 2003;26:570.

  6. Kwar P, Carson I, Clarke R. Haemodynamic changes during induction of anesthesia with midazolam and diazepam in patients undergoing artery bypass surgery. Anesthesia. 1985;40:767.

  7. Russell GN, Wright EL, Fox MA, et al. Propofol-fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass. Anaesthesia. 1989;44:205-208.

  8. Pacheco M. Anestesia intravenosa total con propofol en cirugía cardíaca. Act Anest Reanim. 1994;4:38-4230.

  9. Massey NJA, Sherry KM, Oldroyd S, Peacock JE. Pharmacokinetics of an infusion of propofol during cardiac surgery. Br J Anaesth. 1990;65:475-47932.

  10. Sorbara C, Pittarello D, Rizzoli G, Pasini L, et al. Propofol-fentanyl versus isoflurane fentanyl anesthesia for coronary artery bypass grafting: effect on myocardial contractility and peripheral hemodynamics. J Cardiothorac Vasc Anesth. 1995;9:18-2349.

  11. Dhadphale P, Jackson A, et al. Comparison of anesthesia with diazepam and ketamine versus morphine in patients undergoing heart valve replacement. Anesthesiology. 1979;51:200.

  12. Petel K, Gelman S, McElvein R. Ketamine in patients with pericarditis hemodynamic effects. VI European Congress of Anesthesiology. Anesthesia. 1982;427.

  13. Hudetz JA, Patterson KM, Iqbal Z, et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2009;23:651-657.

  14. Zilberstein G, Levy R, Rachinsky M, Fisher A, Greemberg L, Shapira Y, et al. Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg. 2002;95:531-536.

  15. Michelsen LG, Holford NH. The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg. 2001;93:1100-1105.

  16. Levanen J, Makela M, Scheinin H. Dexmedetomidine premedication attenuates ketamine induced cardiostimulatory effects and posttanesthestic delirium. Anesthesiology. 1995;82:1117.

  17. García A, Rodríguez L. Uso de dexmedetomidina en anestesia total intravenosa (TIVA). Rev Colomb Anestesiol. 2011;39:514-526.

  18. Park KW, Sheela MA. PRO/CON: dexmedetomidine is a useful perioperative adjunct in patients undergoing cardiac surgery. Newsletter Society of Cardiovascular Anesthesiologist.

  19. Anderson K. Total intravenous anesthesia (TIVA): phamacokinetic principles and methods of delivery. The Royal Collage of Anesthestics. 2002;16.

  20. Wood M. Pharmacokinetcs and principles of dugs infusions in cardiac patients. In: Kaplan JA. Cardiac anesthesia. 4th ed. Philadelphia: WB Saunders; 1999. pp. 657-685.

  21. Gravlee GP. Cardiopulmonary bypass: principles and practice. Changes in the pharmacokinetics and pharmacodynamics of drugs administered during cardiopulmonary bypass. Chapter 14. 2nd ed. Lippincott Williams & Wilkins; 2000.

  22. Mets B. The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass. Acta Anaesthesiologica Scandinavica. 2000;44:261-273.

  23. Hudson RJ, Thomson IR. Cardiopulmonary bypass has minimal effects on the pharmacokinetics of fentanyl in adults. Anesthesiology. 2003;99:847-854.

  24. Ayala M. Orientaciones anestésicas actuales en cirugía cardíaca y sus interrelaciones con la circulación extracorpórea. A.E.P. 1991;12:34-39.

  25. Bentyl JB, Conahan TJ, Cork RC. Fentanyl sequestration in lungs during cardiopulmonary bypass. Clin Pharmacol Ther. 1983;34:703-706.

  26. Bovill JG. Intravenous anesthesia for the patient with left ventricular dysfunction. Semin Cardiothorac Vasc Anesth. 2006;10:43.

  27. Butterworth J. Perioperative management of chronic heart failure. Anesth Analg. 2006;103:557-575.

  28. Cortez G. Anestesia basada en la analgesia. Un nuevo paradigma posible. Acta Med CSM. 2008;2:5-10.

  29. Gordon TC, Wong WB. Remifentanil reduces the releace of biochemical markers of myocardial damage after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2010;34:790-795.

  30. Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgery. J Cardiothorac Vasc Anesth. 2007;21:664-671.

  31. De Hert SG, Cromheecke S. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003;99:334-346.

  32. Metz S. Omission of muscle relaxants. Is another clinically available alternative in fast-track cardiac anesthesia. Anesth Analg. 2003;97:1545.

  33. Michelsen LG, Holford NHG. The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg. 2001;93:1100-1105.

  34. Myles PS, Daly DJ. A systematic review of the safety and effectiveness of fast-track cardiac anesthesia. Anesthesiology. 2003;99:982-987.

  35. Bovill JG. Intravenous anesthesia for the patient with left ventricular dysfunction. Semin Cardiothorac Vasc Anesth. 2006;10:43.

  36. Muñoz-Cuevas JH. Sinergia y adición en anestesiología. Revista Mexicana de Anestesiología. 2011;34:S195-S199.

  37. Torres LM. Anestesia intravenosa total. Tratado de anestesia y reanimación II. Cap. 58. Ed. Arán; 2001. pp. 1687-1718.

  38. Tafur LA, Lema E. Anestesia total intravenosa: de la farmacéutica a la farmacocinética. Rev Col Anest. 2010;38:215-231.

  39. Shafer SL, Varvel JR, Aziz N, et al. The pharmacokinetics of fentanyl administered by computer controlled infusion pump. Anesthesiology.1990;73:1091.

  40. Goytia GL, Esquivel V, Gutiérrez H, Rayón AH. Total intravenous anesthesia with propofol and fentanyl: a comparasion of target-controlled versus manual controlled infusion systems. Revista Mexicana de Anestesiología. 2005;28:20-26.

  41. Cheng DC. The efficacy and resource utilization of remifentanil and fentanyl in fast-track artery bypass graff surgery. Anesth Analg. 2001;92:1094-1102.

  42. Russell GN, Wright EL, Fox MA, et al. Propofol-fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass. Anaesthesia. 1989;44:205-208.

  43. Pacheco M. Anestesia intravenosa total con propofol en cirugía cardíaca. Act Anest Reanim. 1994;4:38-4230.

  44. Ahemed M, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg. 2006;103:52-56.




2020     |     www.medigraphic.com